Cancer-testis antigens in ovarian cancer: implication for biomarkers and therapeutic targets

Ovarian cancer remains the most fatal gynecologic malignancy worldwide due to delayed diagnosis as well as recurrence and drug resistance. Thus, the development of new tumor-related molecules with high sensitivity and specificity to replace or supplement existing tools is urgently needed. Cancer-tes...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Ovarian Res
Hauptverfasser: Xie, Kaipeng, Fu, Chenyang, Wang, Suli, Xu, Hanzi, Liu, Siyu, Shao, Yang, Gong, Zhen, Wu, Xiaoli, Xu, Bo, Han, Jing, Xu, Juan, Xu, Pengfei, Jia, Xuemei, Wu, Jiangping
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Review
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6318940/
https://ncbi.nlm.nih.gov/pubmed/30609934
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-018-0475-z
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge